Title |
IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor
|
---|---|
Published in |
Nature Biotechnology, March 2018
|
DOI | 10.1038/nbt.4086 |
Pubmed ID | |
Authors |
Keishi Adachi, Yosuke Kano, Tomohiko Nagai, Namiko Okuyama, Yukimi Sakoda, Koji Tamada |
Abstract |
Infiltration, accumulation, and survival of chimeric antigen receptor T (CAR-T) cells in solid tumors is crucial for tumor clearance. We engineered CAR-T cells to express interleukin (IL)-7 and CCL19 (7 × 19 CAR-T cells), as these factors are essential for the maintenance of T-cell zones in lymphoid organs. In mice, 7 × 19 CAR-T cells achieved complete regression of pre-established solid tumors and prolonged mouse survival, with superior anti-tumor activity compared to conventional CAR-T cells. Histopathological analyses showed increased infiltration of dendritic cells (DC) and T cells into tumor tissues following 7 × 19 CAR-T cell therapy. Depletion of recipient T cells before 7 × 19 CAR-T cell administration dampened the therapeutic effects of 7 × 19 CAR-T cell treatment, suggesting that CAR-T cells and recipient immune cells collaborated to exert anti-tumor activity. Following treatment of mice with 7 × 19 CAR-T cells, both recipient conventional T cells and administered CAR-T cells generated memory responses against tumors. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 45 | 36% |
Japan | 7 | 6% |
United Kingdom | 5 | 4% |
Spain | 4 | 3% |
France | 3 | 2% |
China | 3 | 2% |
Turkey | 1 | <1% |
Sweden | 1 | <1% |
Iraq | 1 | <1% |
Other | 7 | 6% |
Unknown | 47 | 38% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 93 | 75% |
Scientists | 18 | 15% |
Practitioners (doctors, other healthcare professionals) | 8 | 6% |
Science communicators (journalists, bloggers, editors) | 5 | 4% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 677 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 137 | 20% |
Student > Ph. D. Student | 114 | 17% |
Student > Bachelor | 55 | 8% |
Other | 43 | 6% |
Student > Master | 42 | 6% |
Other | 91 | 13% |
Unknown | 195 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 141 | 21% |
Immunology and Microbiology | 101 | 15% |
Agricultural and Biological Sciences | 74 | 11% |
Medicine and Dentistry | 69 | 10% |
Engineering | 23 | 3% |
Other | 64 | 9% |
Unknown | 205 | 30% |